Elevated Creatine Kinase Levels With Second-Generation Antipsychotics

被引:3
|
作者
Agarkar, Smita [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Psychiat, White Plains, NY USA
关键词
SERUM; PSYCHOSIS;
D O I
10.1176/appi.neuropsych.23.3.E49
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:E49 / E50
页数:2
相关论文
共 50 条
  • [21] Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders
    Steen, Nils Eiel
    Aas, Monica
    Simonsen, Carmen
    Dieset, Ingrid
    Tesli, Martin
    Nerhus, Mari
    Gardsjord, Erlend
    Morch, Ragni
    Agartz, Ingrid
    Melle, Ingrid
    Ueland, Torill
    Spigset, Olav
    Andreassen, Ole A.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2017, 18 (06): : 471 - 482
  • [22] Second-generation antipsychotics for obsessive compulsive disorder
    Komossa, Katja
    Depping, Anna M.
    Meyer, Magdalena
    Kissling, Werner
    Leucht, Stefan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (12):
  • [23] Second-generation antipsychotics and bone turnover in schizophrenia
    Okita, Kyoji
    Kanahara, Nobuhisa
    Nishimura, Motoi
    Yoshida, Toshihiko
    Yasui-Furukori, Norio
    Niitsu, Tomihisa
    Yoshida, Taisuke
    Ishikawa, Masatomo
    Kimura, Hiroshi
    Nomura, Fumio
    Iyo, Masaomi
    SCHIZOPHRENIA RESEARCH, 2014, 157 (1-3) : 137 - 141
  • [25] The ups and downs of dosing second-generation antipsychotics
    Citrome, Leslie
    Jaffe, Ari
    Levine, Jerome
    PSYCHIATRIC SERVICES, 2007, 58 (01) : 11 - 11
  • [28] Metabolic risk in selected second-generation antipsychotics
    Kerna, V.
    Nosalova, G.
    Ondrejka, I
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (12): : 640 - 643
  • [29] Interactions between antiepileptics and second-generation antipsychotics
    de Leon, Jose
    Santoro, Vincenza
    D'Arrigo, Concetta
    Spina, Edoardo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (03) : 311 - 334
  • [30] Second-generation antipsychotics and quality of life in schizophrenia
    Leucht, Stefan
    Davis, John M.
    LANCET PSYCHIATRY, 2016, 3 (08): : 694 - 695